As a follow-up to our previous study on benign lymphadenopathies in patients with AD compared to patients without AD, we investigated the same material with IHC markers for IDO1 and PD-L2 and related it to other clinicopathological characteristics. The gene discussed is IDO1; the disease is Alzheimer disease.